Endocan attenuates LPS-induced alveolar type II cells injury through PI3K/Akt/mTOR pathway
Upsala Journal of Medical Sciences · 04.03.2026 · 131 · e13337
DOI: 10.48101/ujms.v131.13337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Upsala Journal of Medical Sciences, online erschienen am 04.03.2026. Verfasst von Zekai Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, School of Basic Medical Sciences, The Research Institute of Microbiota and Host Inflammation-Related Diseases, Wenzhou…. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Lipopolysaccharides, Proto-Oncogene Proteins c-akt, Proteoglycans. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Alveolar type II (AT2) cell injury plays an important role in the pathogenesis of acute lung injury (ALI), but the corresponding treatment options are limited in clinical practice. Endocan has been proved to exert a protective effect in ALI, however, the underlying mechanism remains unclear. The phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mechanistic target of rapamycin (mTOR) signaling pathway was found to exhibit beneficial effects in lipopolysaccharide-induced ALI. This study aimed to investigate protective effects of endocan on AT2 cells and the signal pathway in LPS-induced ALI.
Methods
Pulmonary function testing and hematoxylin–eosin staining were employed to evaluate the effects of endocan on the LPS-induced ALI in mice. Transmission electron microscopy (TEM) analysis, immunofluorescence and Western blot were used to assess the AT2 protection of endocan. Mouse lung epithelial cell line 12 (MLE-12) cells were facilitated to observe the activation of PI3K/AKT/mTOR pathway.
Results
Endocan administration effectively ameliorated respiratory parameters in LPS-challenged ALI mice. TEM revealed that endocan treatment preserved AT2 cell integrity and maintained lamellar body ultrastructure compared to the mice injected LPS only. Western blot analysis showed a higher surfactant protein C expression in endocan-treated mice than that of model group. Moreover, the phosph-PI3K, -AKT, -mTOR levels detected by Western blot were significantly observed upregulated after endocan treatment. However, rapamycin, an mTOR inhibitor, abolished the protective effects of endocan against ALI, indicating this pathway may be critical for its action on AT2 cells. In LPS-treated MLE-12 cells, the Western blot analysis further confirmed that rapamycin suppressed endocan-induced activation of the PI3K/AKT/mTOR pathway, thereby attenuating the protective effects of endocan on MLE-12 cells.
Conclusion
Endocan protects AT2 cells against ALI through activating PI3K/AKT/mTOR pathway, suggesting its therapeutic potential for AT2 in patients with ALI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, School of Basic Medical Sciences, The Research Institute of Microbiota and Host Inflammation-Related Diseases, Wenzhou Medical University, Wenzhou, China.
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
- Department of Anesthesiology, Critical Care and Pain Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
- Department of Chemical and Environmental Engineering, The University of Nottingham Ningbo China, Ningbo, PR China.
ORCID-Profile: Zekai Wang, Yulu Zhao, Ming Luo, Jinling Yang, Zhixiang Geng, Shining Ou, Zhenxuan Huang, Ruiqi Sun, Xiang Luo, Keke Jin, Fangyan Wang, Xiaolong Zhang
Zitieren
APA
Wang, Z., Zhao, Y., Luo, M., Yang, J., Geng, Z., Ou, S., Huang, Z., Sun, R., Luo, X., Jin, K., Wang, F., & Zhang, X. (2026). Endocan attenuates LPS-induced alveolar type II cells injury through PI3K/Akt/mTOR pathway. Upsala Journal of Medical Sciences, 131, e13337. https://doi.org/10.48101/ujms.v131.13337
Vancouver
Wang Z, Zhao Y, Luo M, Yang J, Geng Z, Ou S, et al. Endocan attenuates LPS-induced alveolar type II cells injury through PI3K/Akt/mTOR pathway. Upsala Journal of Medical Sciences. 2026;131:e13337. doi:10.48101/ujms.v131.13337
BibTeX
@article{Wang2026,
author = {Wang, Zekai and Zhao, Yulu and Luo, Ming and Yang, Jinling and Geng, Zhixiang and Ou, Shining and Huang, Zhenxuan and Sun, Ruiqi and Luo, Xiang and Jin, Keke and Wang, Fangyan and Zhang, Xiaolong},
title = {Endocan attenuates LPS-induced alveolar type II cells injury through PI3K/Akt/mTOR pathway},
journal = {Upsala Journal of Medical Sciences},
year = {2026},
volume = {131},
pages = {e13337},
doi = {10.48101/ujms.v131.13337}
}
EUVIMED